JPRN-UMIN000016963
Completed
未知
Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for early gastric cancer - Sentinel node biopsy guided by indocyanine green fluorescence imaging for early gastric cancer
Department of Gastroenterological Surgery, Osaka University0 sites30 target enrollmentMarch 29, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Gastroenterological Surgery, Osaka University
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Allergy for indocyanine green or iodine. 2\) Cannot enroll to this study for any other reasons.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancercolon cancerJPRN-UMIN000029159Department of Gastroenterological Surgery, Osaka University30
Recruiting
Not Applicable
Feasibility study on sentinel lymph node biopsy after neoadjuvant chemotherapy in node positive patients with breast cancerBreast cancer with pocitive axillary node treated by neoadjuvant chemotherapyJPRN-UMIN000003015Department of Breast and Endocrine Surgery, Kumamoto University50
Completed
Phase 2
Feasibility study of sentinel lymph node biopsy in oral and laryngo-pharyngeal cancer patients using an indocyanine green fluorescence method and a radioisotope method.Oral and pharyngo-laryngeal cancerJPRN-UMIN000006509Aichi Cancer Center20
Completed
Phase 2
Sentinel lymph node biopsy feasibility study in patients with primary cutaneous melanomaMelanomaCancerISRCTN80602070Sponsor not defined - Record supplied by Institute of Cancer Research120
Completed
Not Applicable
Feasibility study of sentinel lymph node biopsy following neoadjuvant chemotherapy in breast cancer patientsJPRN-UMIN000006534Sentinel Lymph node biopsy following neoadjuvant chemotherapy240